Lots of antibodies to create confusion: heterophile, IgM-VCA, IgG-VCA, IgG-EBNA, IgG-EA. Do you know their significance?
Did you know that we should repeat titers at 6 and 12 months after treating a patient for syphilis?
What’s the difference between PrEP and PEP? How effective are they? Who’s eligible?
Febrile infants have higher rates of invasive bacterial infections. Do you know what work-up is recommended?
Recognizing monkeypox can be tricky–better add it to your differential.
For HIV-uninfected patients, pre-exposure prophylaxis (PrEP) using antiretroviral medications is an evidence-based way to prevent new infections among those at high risk for HIV. Typical use is once daily every day, but what about on-demand use?
Let’s review some updates on forum topics from the past year: lung cancer screening, gonorrhea testing and management, and primary aldosteronism.
What’s the diagnostic criteria for chronic hepatitis B (CHB)? What serology findings do these patients have in common? What studies should we monitor in these patients? And how do we differentiate the phases of CHB?
What does it mean to have positive anti-HBs? Why don’t we ever check HBcAg? And how does seroconversion affect our interpretation of acute and chronic HBV?
How common is trichomoniasis? Why doesn’t routine STI screening include testing for trichomonas? And how do we test for it?